Dr. Pasbrig joined Alusuisse Lawson Mardon in 1990, and over the next 20 years, he led R&D and technology development of aluminum in pharmaceutical and medical device applications. While he was working there, Alusuisse was acquired by Alcan, which was then acquired by Amcor. Dr. Pasbrig is a leader with wide expertise in high barrier pharmaceutical packaging, especially Alu/Alu or Cold Formed Foil (CFF). He left Amcor in 2012 to become an independent consultant.
This person is not in the org chart
This person is not in any offices